Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
JCI Insight ; 3(12)2018 06 21.
Article in English | MEDLINE | ID: mdl-29925691

ABSTRACT

AMPK activated protein kinase (AMPK), a master regulator of energy homeostasis, is activated in response to an energy shortage imposed by physical activity and caloric restriction. We here report on the identification of PAN-AMPK activator O304, which - in diet-induced obese mice - increased glucose uptake in skeletal muscle, reduced ß cell stress, and promoted ß cell rest. Accordingly, O304 reduced fasting plasma glucose levels and homeostasis model assessment of insulin resistance (HOMA-IR) in a proof-of-concept phase IIa clinical trial in type 2 diabetes (T2D) patients on Metformin. T2D is associated with devastating micro- and macrovascular complications, and O304 improved peripheral microvascular perfusion and reduced blood pressure both in animals and T2D patients. Moreover, like exercise, O304 activated AMPK in the heart, increased cardiac glucose uptake, reduced cardiac glycogen levels, and improved left ventricular stroke volume in mice, but it did not increase heart weight in mice or rats. Thus, O304 exhibits a great potential as a novel drug to treat T2D and associated cardiovascular complications.


Subject(s)
AMP-Activated Protein Kinases/drug effects , AMP-Activated Protein Kinases/metabolism , Diabetes Mellitus, Type 2/metabolism , Glucose/metabolism , Heterocyclic Compounds/pharmacology , Homeostasis , Animals , Blood Glucose/drug effects , Blood Pressure , Cardiomegaly , Cardiovascular Diseases , Glycogen/metabolism , Heart , Holoprosencephaly/prevention & control , Humans , Insulin Resistance , Insulin-Secreting Cells , Jaw Abnormalities/prevention & control , Metformin/therapeutic use , Mice , Mice, Obese , Muscle, Skeletal/drug effects , Muscle, Skeletal/metabolism , Rats , Stroke Volume
2.
Genet Couns ; 1(3-4): 197-210, 1990.
Article in English | MEDLINE | ID: mdl-2098044

ABSTRACT

Cerebral midline anomalies are defects of anatomical relationships between the two hemispheres. They include holoprosencephalies, septal and commissural agenesis. Agenesis of the olfactory tract (arhinencephalies) are often included in the spectrum of holoprosencephalies and the facial phenotype is thought to be affected and characteristic in the midline development abnormalities. This work concerns a review of the literature and personal experience in two units of Fetopathology in Paris. This study confirms the relationships between various cerebral malformations and their frequent association. However, arhinencephaly and moreover agenesis of corpus callosum should be considered as heterogeneous entities, often totally distinct and independent from the malformative process of the holoprosencephaly. In addition, if major facial anomalies such as cyclopia are almost pathognomonic for holoprosencephaly, minor malformations such as lateral facial clefts of cleft palates result from a great variety of malformative processes.


Subject(s)
Abnormalities, Multiple/genetics , Brain/abnormalities , Chromosome Aberrations/genetics , Facial Bones/abnormalities , Holoprosencephaly/genetics , Skull/abnormalities , Abnormalities, Multiple/pathology , Abnormalities, Multiple/prevention & control , Brain/pathology , Chromosome Aberrations/pathology , Chromosome Aberrations/prevention & control , Chromosome Disorders , Female , Holoprosencephaly/pathology , Holoprosencephaly/prevention & control , Humans , Infant, Newborn , Pregnancy
SELECTION OF CITATIONS
SEARCH DETAIL
...